APPLICATION
NDA210607
TYPE
NDA
ORIGINAL APPROVAL
2018-08-08
LATEST ACTION
2022-02-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ARAKODA · ReferencePrescription
TAFENOQUINE SUCCINATE EQ 100MG BASE · TABLET · ORAL
Approval history
2022-02-25Manufacturing (CMC) · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.